Insmed Inc’s recent filing unveils that its Director LEE LEO unloaded Company’s shares for reported $14.69 million on Nov 17 ’25. In the deal valued at $195.90 per share,75,000 shares were sold. As a result of this transaction, LEE LEO now holds 54,677 shares worth roughly $10.87 million.
Then, ANDERSON ELIZABETH M sold 10,000 shares, generating $1,958,700 in total proceeds. Upon selling the shares at $195.87, the Director now owns 63,729 shares.
Before that, Leo Lee bought 75,000 shares. Insmed Inc shares valued at $14,491,500 were divested by the Director at a price of $193.22 per share.
A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in mid October with a ‘”an Overweight”‘ rating. William Blair began covering INSM with “an Outperform” recommendation on August 20, 2025. Morgan Stanley revised its rating on August 13, 2025. It rated INSM as “an Equal-weight” which previously was an “an Overweight”.
Price Performance Review of INSM
On Friday, Insmed Inc [NASDAQ:INSM] saw its stock fall -0.44% to $198.76. Over the last five days, the stock has gained 2.87%. Insmed Inc shares have risen nearly 169.61% since the year began. Nevertheless, the stocks have risen 187.89% over the past one year. While a 52-week high of $208.00 was reached on 11/20/25, a 52-week low of $60.40 was recorded on 04/09/25.
Levels Of Support And Resistance For INSM Stock
The 24-hour chart illustrates a support level at 195.13, which if violated will result in even more drops to 191.49. On the upside, there is a resistance level at 201.92. A further resistance level may holdings at 205.07.
How much short interest is there in Insmed Inc?
A steep rise in short interest was recorded in Insmed Inc stocks on 2025-10-31, dropping by -2.69 million shares to a total of 8.03 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 10.73 million shares. There was a decline of -33.54%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on May 13, 2025 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $105 price target.
